Company Profiles

driven by the PitchBook Platform

Promethera Biosciences

Description

Developer of products based on stem cell technology to treat liver diseases. The company discovers, develops and commercializes cell therapy products using allogenic progenitor cells harvested from healthy human livers.

2009

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$11M

Latest Deal Amount

$81.6M

Total Amount Raised

Description

Developer of products based on stem cell technology to treat liver diseases. The company discovers, develops and commercializes cell therapy products using allogenic progenitor cells harvested from healthy human livers.

Website:

www.promethera.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

Watson & Crick Hill Rue Granbonpré, 11 B-1435 Mont-Saint-GuibertBelgium +32 (0)1 039 43 00
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Promethera Biosciences's full profile, request a free trial.

Promethera Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Promethera Biosciences Investors (22)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Advanced Technology MaterialsCorporationMinority000 0000000 0000
Boehringer Ingelheim Venture FundCorporate Venture CapitalMinority000 0000000 0000
Capital & CroissanceVenture CapitalMinority000 0000000 0000
Cell Innovation PartnersOtherMinority000 0000000 0000
Federal Holding and Investment CompanyPE/BuyoutMinority000 0000000 0000
Advanced Technology Materials Corporation
Boehringer Ingelheim Venture Fund Corporate Venture Capital
Capital & Croissance Venture Capital
Cell Innovation Partners Other
Federal Holding and Investment Company PE/Buyout

Promethera Biosciences Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Etienne Sokal Ph.DFounder, Board Member & Chief Innovation and Scientific Officer
John Tchelingerian Ph.DChief Executive Officer & Chairman of the Board
Frank HazevoetsChief Financial Officer & Head, Corporate Development
Torsten Hombeck Ph.DChief Commercial & Strategy Officer
Jürgen BeckVice President, Clinical & Medical Affairs
Etienne Sokal Ph.D Founder, Board Member & Chief Innovation and Scientific Officer
John Tchelingerian Ph.D Chief Executive Officer & Chairman of the Board
Frank Hazevoets Chief Financial Officer & Head, Corporate Development
Torsten Hombeck Ph.D Chief Commercial & Strategy Officer
Jürgen Beck Vice President, Clinical & Medical Affairs

Promethera Biosciences Board Members (9)

NameRepresentingRoleSinceContact
Info
Alain ParthoensVesalius BiocapitalManaging Partner000 0000
Charlie AlexanderPromethera BiosciencesBoard Member & Board Observer000 0000
Etienne Sokal Ph.DPromethera BiosciencesFounder, Board Member & Chief Innovation and Scientific Officer000 0000
Ilka Wicke Ph.DBoehringer IngelheimBoard Member000 0000
Ingo KoesfeldPromethera BiosciencesBoard Member & Board Observer000 0000
Alain Parthoens Managing Partner Vesalius Biocapital
Charlie Alexander Board Member & Board Observer Promethera Biosciences
Etienne Sokal Ph.D Founder, Board Member & Chief Innovation and Scientific Officer Promethera Biosciences
Ilka Wicke Ph.D Board Member Boehringer Ingelheim
Ingo Koesfeld Board Member & Board Observer Promethera Biosciences
Request full access to PitchBook